REFRACTORY SOLID TUMORS
Clinical trials for REFRACTORY SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMORS trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: experimental drug PEEL-224 enters trials
Disease control Recruiting nowThis study tests a new drug called PEEL-224, alone or with standard chemotherapy, in children and young adults whose solid tumors have not responded to treatment or have returned. The first part finds the safest dose, and the second part measures how well the drug combination shr…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Theodore Laetsch • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to tackle childhood cancers that Won't quit
Disease control Recruiting nowThis early-phase trial is testing whether adding a drug called eribulin to two standard chemotherapy drugs (irinotecan and temozolomide) is safe for children and young adults up to age 25 with solid tumors that have returned or not responded to treatment. The main goal is to find…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Massive study aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study is collecting medical information and biological samples from up to 10,000 people with rare solid tumors, their relatives, and those with genetic mutations that raise cancer risk. Researchers hope to learn how these tumors develop and change over time. The goal is to i…
Matched conditions: REFRACTORY SOLID TUMORS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC